rs7391474
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000808.4(GABRA3):c.-117A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.73 ( 21039 hom., 23265 hem., cov: 22)
Exomes 𝑓: 0.80 ( 18 hom. 67 hem. )
Failed GnomAD Quality Control
Consequence
GABRA3
NM_000808.4 5_prime_UTR
NM_000808.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0520
Genes affected
GABRA3 (HGNC:4077): (gamma-aminobutyric acid type A receptor subunit alpha3) GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant X-152451236-T-G is Benign according to our data. Variant chrX-152451236-T-G is described in ClinVar as [Benign]. Clinvar id is 1241796.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.705 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRA3 | NM_000808.4 | c.-117A>C | 5_prime_UTR_variant | 1/10 | ENST00000370314.9 | NP_000799.1 | ||
GABRA3 | XM_006724811.4 | c.-117A>C | 5_prime_UTR_variant | 1/9 | XP_006724874.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRA3 | ENST00000370314.9 | c.-117A>C | 5_prime_UTR_variant | 1/10 | 1 | NM_000808.4 | ENSP00000359337 | P1 |
Frequencies
GnomAD3 genomes AF: 0.729 AC: 79544AN: 109076Hom.: 21046 Cov.: 22 AF XY: 0.728 AC XY: 23247AN XY: 31936
GnomAD3 genomes
AF:
AC:
79544
AN:
109076
Hom.:
Cov.:
22
AF XY:
AC XY:
23247
AN XY:
31936
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.804 AC: 115AN: 143Hom.: 18 Cov.: 0 AF XY: 0.848 AC XY: 67AN XY: 79
GnomAD4 exome
AF:
AC:
115
AN:
143
Hom.:
Cov.:
0
AF XY:
AC XY:
67
AN XY:
79
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.729 AC: 79544AN: 109125Hom.: 21039 Cov.: 22 AF XY: 0.727 AC XY: 23265AN XY: 31997
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
79544
AN:
109125
Hom.:
Cov.:
22
AF XY:
AC XY:
23265
AN XY:
31997
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 28, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at